Screening and treatment for major depressive disorder in children and adolescents: US Preventive Services Task Force Recommendation Statement.
about
International Committee on Mental Health in Cystic Fibrosis: Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus statements for screening and treating depression and anxietyThe treatment of depressive disorders in children and adolescentsUniversal mental health screening in pediatric primary care: a systematic reviewSafety and tolerability of desvenlafaxine in children and adolescents with major depressive disorder.Criterion validity of the Short Mood and Feelings Questionnaire and one- and two-item depression screens in young adolescents.National quality measures for child mental health care: background, progress, and next steps.Evidence for the management of adolescent depression.The association between major depressive disorder and obesity in US adolescents: results from the 2001-2004 National Health and Nutrition Examination Survey.Pediatric depression: an evidence-based update on treatment interventionsAdult depression screening in Saudi primary care: prevalence, instrument and cost.Detecting depression among adolescents in Santiago, Chile: sex differencesThe p4 screener: evaluation of a brief measure for assessing potential suicide risk in 2 randomized effectiveness trials of primary care and oncology patientsCOPE for depressed and anxious teens: a brief cognitive-behavioral skills building intervention to increase access to timely, evidence-based treatmentEvaluation of the PHQ-2 as a brief screen for detecting major depression among adolescentsDepressive symptoms in severely obese compared with normal weight adolescents: results from a community-based longitudinal study.Characterization of depression in children with autism spectrum disorders.Evidence-based clinical guidelines for immigrants and refugees.Screen teens for depression--it's quicker than you thinkPsychological screening in adolescents with type 1 diabetes predicts outcomes one year later.Evaluation of the Patient Health Questionnaire-9 Item for detecting major depression among adolescentsHow poorer quality of life in adolescence predicts subsequent type 1 diabetes management and control.Suicide in pediatrics: epidemiology, risk factors, warning signs and the role of the pediatrician in detecting themChallenges in the diagnosis and treatment of depression in autism spectrum disorders across the lifespanMedication beliefs mediate between depressive symptoms and medication adherence in cystic fibrosis.Accuracy of Depression Screening Tools to Detect Major Depression in Children and Adolescents: A Systematic Review.Barriers and facilitators for mental healthcare in pediatric lupus and mixed connective tissue disease: a qualitative study of youth and parent perspectivesEfficacy of metabolic and psychological screening for mood disorders among children with type 1 diabetesIncreases in behavioral health screening in pediatric care for Massachusetts Medicaid patients.Depression screening and mental health outcomes in children and adolescents: a systematic review protocol.Providing depression care in the medical home: what can we learn from attention-deficit/ hyperactivity disorder?Emergency Department Screening for Adolescent Mental Health Disorders: The Who, What, When, Where, Why and How It Could and Should Be Done.What clinical differences distinguish depressed teens with and without comorbid externalizing problems?Predicting future depression in adolescents using the Short Mood and Feelings Questionnaire: a two-nation studyLongitudinal associations between depression and problematic substance use in the Youth Partners in Care study.Twelve-month suicidal symptoms and use of services among adolescents: results from the National Comorbidity Survey.Identifying Differences in Risk Factors for Depression and Anxiety in Pediatric Chronic Disease: A Matched Cross-Sectional Study of Youth with Lupus/Mixed Connective Tissue Disease and Their Peers with Diabetes.Depression screening in adolescents in the United States: a national study of ambulatory office-based practice.Systematic Review of Clinical Practice Guidelines for Failed Antidepressant Treatment Response in Major Depressive Disorder, Dysthymia, and Subthreshold Depression in Adults.Systematic Review of Screening Instruments for Psychosocial Problems in Children and Adolescents With Long-Term Physical Conditions.World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of unipolar depressive disorders, part 1: update 2013 on the acute and continuation treatment of unipolar depressive disorders.
P2860
Q26785374-CF702585-B62A-47E8-8642-ED510299E430Q26998760-891C8C5A-3628-4C75-A108-D4AAECF44FA8Q30573389-A27E053D-3975-4A23-BEB9-C1EB55337562Q33632399-DF49FA95-4066-41DE-8E13-304ADB43239DQ33692060-9B4BDBDA-EB57-4850-92D4-EE9BA57D6B71Q33715076-2FF699EF-A060-4235-8A29-1ABF0A7D615DQ33819692-6A5C9412-74E9-4469-AEF9-25F28CD8BAC3Q34040061-7B582DC4-BAEF-40E4-A50A-2EA602FA9C48Q34359585-32D05711-56AD-4D1F-8099-BEB72F52AA98Q34485868-7E808A96-2C64-4002-AC86-E5BD462B75C3Q34686884-FD3E506F-2B5D-4480-AE99-1894367DED9DQ34743098-1F6AFD98-A08B-4EBF-A790-E238051EC860Q34949501-C6231CFA-446A-4969-B370-1596CB9788BFQ35002061-4225EF5D-7AA3-488F-AC74-906D0B991436Q35072343-0FCBBC14-BB87-4704-8C80-948F72EC3656Q35158879-77518630-BDBB-422D-9205-FA7D11C9FB6DQ35201293-776C7ED6-ABBE-452A-A253-E3300BF10F61Q35247287-45B030FD-A38F-4C9E-8D04-356D87020902Q35341396-4C1E983A-C1CE-4EA6-9113-E8609E15D33CQ35554698-E9459A25-336E-4509-B18D-4E9007E84D29Q35742920-C6D1A2F8-BC51-4B26-8015-4BFEE7C730C7Q35828149-5F6DD038-7A74-4DEF-AE1D-DC4612D87828Q35899465-E45BAF74-DED5-4DD4-B183-6A55568A3400Q35955792-96FDC289-27AA-421F-9491-586186CA0F82Q36054234-57764FE9-9FB4-46D0-AC58-DF671DA14BC7Q36310919-6A1A85A6-14F9-4563-899C-A135A9FEFF9DQ36334660-41766759-73C9-42C5-BC39-C1D8BDF1C647Q36504206-0FB4AE15-AB96-4922-9091-6092C3FE12FAQ36585408-F8D0767D-E45B-4B6C-9BC1-93CA1CC99DAAQ36713657-04BF5737-8E29-4EE1-8546-9A8C5DC39986Q36839246-F06441F3-5DCD-4D74-A4E2-A66089A75EE8Q36955173-2C95116D-58FC-4A34-8E95-202DCCB6A27AQ37073973-E3B8812D-7120-476A-BE62-E635365B79F3Q37138249-96FC9156-24DC-4797-8A76-348BB97A82F8Q37400348-3D4ED6CB-4EFD-446C-B5AB-A6A8D07164F2Q37621292-8C9B118B-5B03-41B1-8BE6-E67DBBEB1881Q37632212-68AFB3E7-3436-454B-9FD9-AB3058E8E02BQ37635714-A27B2412-BABD-488C-BE1B-A3201EDF040CQ37650133-A5413C1C-0DBE-4657-9B79-E67EC75D9DF1Q38123516-879AF65C-1B4A-4D0B-BBAB-363BB5E031F8
P2860
Screening and treatment for major depressive disorder in children and adolescents: US Preventive Services Task Force Recommendation Statement.
description
2009 nî lūn-bûn
@nan
2009 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Screening and treatment for ma ...... orce Recommendation Statement.
@ast
Screening and treatment for ma ...... orce Recommendation Statement.
@en
Screening and treatment for ma ...... orce Recommendation Statement.
@nl
type
label
Screening and treatment for ma ...... orce Recommendation Statement.
@ast
Screening and treatment for ma ...... orce Recommendation Statement.
@en
Screening and treatment for ma ...... orce Recommendation Statement.
@nl
prefLabel
Screening and treatment for ma ...... orce Recommendation Statement.
@ast
Screening and treatment for ma ...... orce Recommendation Statement.
@en
Screening and treatment for ma ...... orce Recommendation Statement.
@nl
P356
P1433
P1476
Screening and treatment for ma ...... orce Recommendation Statement.
@en
P2093
US Preventive Services Task Force
P304
P356
10.1542/PEDS.2008-2381
P407
P577
2009-04-01T00:00:00Z